ACP
MEDP icon

Arcus Capital Partners’s Medpace MEDP Stock Holding History

Arcus Capital Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-965
Closed -$390K – 132
2024
Q4 		$390K Buy
+965
New +$327K 0.12% 74
2024
Q2 		– Sell
-965
Closed -$390K – 120
2024
Q1 		$390K Buy
965
+131
+16% +$46.1K 0.12% 74
2023
Q4 		$256K Buy
+834
New +$225K 0.09% 87

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Arcus Capital Partners's MEDP Position: Q1 2025 in Review

Arcus Capital Partners sold out of Medpace (MEDP) in Q1 2025, closing a stake of 965 shares — an estimated $390K sold.

Arcus Capital Partners first reported a position in MEDP in Q4 2023 and held it in 3 quarters. The position peaked at $390K in Q4 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Arcus Capital Partners reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • Arcus Capital Partners sold 965 Medpace shares in Q1 2025, an estimated $390K.
  • Arcus Capital Partners first reported a position in Medpace in Q4 2023 and held it in 3 quarters.
  • Arcus Capital Partners's Medpace position peaked at $390K in Q4 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Arcus Capital Partners's 13F filing for Q1 2025, filed 30 Apr 2025.